Daré Bioscience, Inc.
Daré Bioscience, Inc. (DARE) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
dare · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Daré Bioscience, Inc. (DARE) measures how much investors pay for each dollar of the company's trailing earnings. DARE's current PE ratio of N/A is calculated by dividing its stock price of $1.85 by its TTM earnings per share of -$0.83.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2011 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Daré Bioscience, Inc.You DARE | $18M | N/A | — | -$0.83 |
 Aditxt, Inc. ADTX | $0M | N/A | — | -$1116.70 |
 Ainos, Inc. AIMD | $9M | N/A | — | -$3.46 |
 Adlai Nortye Ltd. ANL | $543M | N/A | — | -$3.33 |
 Aspire Biopharma Holdings, Inc. ASBP | $1M | N/A | — | -$16.38 |
 Athira Pharma, Inc. ATHA | $27M | N/A | — | -$24.70 |
 Citius Pharmaceuticals, Inc. CTXR | $7M | N/A | — | -$3.38 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.12 | — | |
2024-12-31 FY2024 | — | $-0.48 | — | |
2023-12-31 FY2023 | — | $-4.15 | — | |
2022-12-31 FY2022 | — | $-4.39 | — | |
2021-12-31 FY2021 | — | $-7.59 | — | |
2020-12-31 FY2020 | — | $-10.93 | — | |
2019-12-31 FY2019 | — | $-10.99 | — | |
2018-12-31 FY2018 | — | $-18.72 | — | |
2017-12-31 FY2017 | — | $-42.71 | — | |
2016-12-31 FY2016 | — | $-14.18 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Daré Bioscience, Inc. (DARE) measures how much investors pay for each dollar of the company's trailing earnings. DARE's current PE ratio of N/A is calculated by dividing its stock price of $1.85 by its TTM earnings per share of -$0.83.
Frequently asked questions
DARE pe ratio · 6 questionsDARE's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.85 and TTM EPS of -$0.83. Data sourced from Financial Modeling Prep via DARE's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Daré Bioscience, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09